106 related articles for article (PubMed ID: 9135005)
1. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells.
Jing Y; Waxman S; Mira-y-Lopez R
Cancer Res; 1997 May; 57(9):1668-72. PubMed ID: 9135005
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
3. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
Donato LJ; Noy N
Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion.
Vo HP; Crowe DL
Anticancer Res; 1998; 18(1A):217-24. PubMed ID: 9568080
[TBL] [Abstract][Full Text] [Related]
5. AP2 transcription factors regulate expression of CRABPII in hormone responsive breast carcinoma.
McPherson LA; Woodfield GW; Weigel RJ
J Surg Res; 2007 Mar; 138(1):71-8. PubMed ID: 17187826
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
8. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
10. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the laminin beta 1 (LAMB1), retinoic acid receptor beta, and bone morphogenetic protein 2 genes in mutant F9 teratocarcinoma cell lines partially deficient in cyclic AMP-dependent protein kinase activity.
Shen J; Li C; Gudas LJ
Cell Growth Differ; 1997 Dec; 8(12):1297-304. PubMed ID: 9419418
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
[TBL] [Abstract][Full Text] [Related]
13. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
Chen H; Zhang H; Lee J; Liang X; Wu X; Zhu T; Lo PK; Zhang X; Sukumar S
Cancer Res; 2007 Sep; 67(17):8007-13. PubMed ID: 17804711
[TBL] [Abstract][Full Text] [Related]
14. Mammary carcinoma suppression by cellular retinoic acid binding protein-II.
Manor D; Shmidt EN; Budhu A; Flesken-Nikitin A; Zgola M; Page R; Nikitin AY; Noy N
Cancer Res; 2003 Aug; 63(15):4426-33. PubMed ID: 12907615
[TBL] [Abstract][Full Text] [Related]
15. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
Chen AC; Guo X; Derguini F; Gudas LJ
Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581
[TBL] [Abstract][Full Text] [Related]
16. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid down-regulates the expression of the vasoactive intestinal polypeptide receptor type-1 in human breast carcinoma cell lines.
Madsen B; Georg B; Vissing H; Fahrenkrug J
Cancer Res; 1998 Nov; 58(21):4845-50. PubMed ID: 9809989
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
19. The H-ras oncogene interferes with retinoic acid signaling and metabolism in NIH3T3 cells.
Kósa K; Jones CS; De Luca LM
Cancer Res; 1995 Nov; 55(21):4850-4. PubMed ID: 7585519
[TBL] [Abstract][Full Text] [Related]
20. Competitive PCR demonstrates that 9-cis retinoic acid induces cellular retinoic acid-binding protein-II more efficiently than all-trans retinoic acid in human osteosarcoma cells.
Melhus H; Gobl A; Ljunghall S
Biochem Biophys Res Commun; 1994 Apr; 200(2):1125-9. PubMed ID: 8179592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
